Veyong Pharma Ya Wuce Sabon Binciken GMP tare da Babban Matsayi

Daga ranar 23 ga Afrilu zuwa 24 ga watan Afrilu, kungiyar kwararrun likitocin dabbobi ta GMP mai mutum 5 ta gudanar da sabon binciken GMP na kamfanin Hebei Veyong Pharmaceutical Co., Ltd. Shugabannin da suka dace na Ofishin Noma na Birane da Ofishin Jarrabawa da Amincewa sun shiga cikin shaida a matsayin masu sa ido. , da kuma daraktocin sashen kamfanin da ma'aikatan da suka dace na ƙungiyar aikin sun shiga cikin aikin karɓa.

Kungiyar kwararru ta fara sauraren gabatar da babban manajan Li Jianjie game da halin da ake ciki na Veyong Pharma da aiwatar da sabon tsarin GMP, tare da zurfafa fahimtar muhimman ayyukan gyare-gyare da sabbin ayyuka.Dangane da sabbin ka'idojin GMP, ƙwararrun ƙungiyar sun gudanar da bincike a kan kayan aikin kamfanin, gudanarwar rukunin yanar gizon, da ayyukan ma'aikata na shirye-shirye da samar da API, kuma sun sake dubawa da bincike game da takaddun da ke da alaƙa da GMP, bayanai da sauran su. kayan aikin software.

Layukan samarwa da aka duba sun haɗa da: allurar foda, foda / pulvis, premix, bolus / kwamfutar hannu, granule (ciki har da hakar likitancin kasar Sin), allurar da ba ta ƙarshe ba, allura mai girma mara ƙarfi ta ƙarshe (ciki har da hakar likitancin Sinanci). ), alluran da ba za a iya jurewa ba (ciki har da hakar magungunan kasar Sin), hanyoyin maganin baka (ciki har da hakar magungunan kasar Sin), magungunan kashe kwari na waje, da magungunan kashe kwayoyin cutar da ba na chlorine da sauransu 11 na shirye-shiryen karshe na samar da magunguna 11, Cire magungunan kasar Sin guda 8 da Ivermectin, EprinomectinValnemulin hydrochloride,Tiamulin hydrogen fumarate, oxytetracycline hydrochloride, Closantel sodium, AbamectinTilmicosin, Tilmisocin phosphate,tyvanosin tartrate, Tildipirosin,Florfenicolda doxycycline hydrochloride 13 API kayayyakin.

A lokacin binciken, ƙungiyar ƙwararrun ta bayyana cewa gabaɗayan matakin sabon aikin GMP na Veyongl yana da girma, kuma software da kayan masarufi sun cika daidaitattun buƙatun.Babban ma'auni na samar da kayan aiki da kayan aiki ya gane kulawar hankali da dijital na tsarin samarwa.Layukan samar da ƙwayoyin cuta, foda, pulvis, premix, da allura sun cancanci koyo daga masana'antar;da dubawa kewayon ne cikakke, ciki har da duka albarkatun kasa da shirye-shirye, da kuma fiye da 20 samar Lines da aka wuce a lokaci guda; Veyong ya ci gaba da ƙara da zuba jari a cikin aminci da muhalli kare a tsawon shekaru, gina wani aminci da kuma kaifin baki dandali, kunna ma'aikata. tsarin sanyawa, kuma an karɓi ci-gaba na kare muhalli kamar RTO don kare muhalli.A ƙarshe, ƙungiyar ƙwararrun ƙwararrun ma'aikatar aikin gona ta amince da gaba ɗaya cewa layin shirye-shirye 11 da samfuran API 13 na Hebei Veyong Pharmaceutical Co., Ltd. sun wuce binciken sabon GMP tare da babban maki.

Zhang Qing, shugaban kamfanin Veyong, ya bayyana cewa, binciken sabon GMP ba wani mataki ne na karshe ba ga Veyong, amma sabon mafari ne.Dole ne mu zurfafa nazarin ainihin sabon gudanarwar GMP da aiwatar da gudanarwa mai ƙarfi na GMP, farawa daga wannan binciken, shirya samarwa da ayyuka da yawa daidai da buƙatun GMP, ci gaba da haɓaka matakin gudanarwa mai inganci, da haɓaka zuwa matakin farko na gida. kamfanoni da ka'idojin ingancin samfur na duniya.

Nasarar wucewar sabon binciken GMP ya nuna cewa gudanarwar Veyong ta kai wani sabon mataki.Veyong zai dauki wannan binciken a matsayin wata dama ta ci gaba da bin dabarun kasuwanci na hadewar fasahar fasaha da magunguna, tare da bin manufar "Sinanci. dabbobi magani, Veyong ta Quality", dogara a kan abũbuwan amfãni daga albarkatun kasa da kuma shirye-shirye kamar ivermectin, Eprinomectin, da tiamulin fumarate, za mu hanzarta R & D da aikace-aikace na shirye-shirye na tyvanosin tartrate da tilmicosin, da sauransu.Za mu samar da wani sabon mataki na ci gaban kamfanin na Veyong, da samar da kayayyaki masu inganci ga masana'antar kiwo ta duniya, da taimakawa ci gaban lafiya da inganci na masana'antar kiwon lafiyar dabbobi ta kasar Sin.

Hotunan samarwa